ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

February 25, 2011

Civin Moves From Hopkins To Maryland To Direct Stem Cell Medicine Center

January 9, 2009

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983

Francis Collins Nominated For NIH Director Two Days After Final Stem Cell Guidelines Released.

July 10, 2009

Daily Humidification Improves Quality-of-Life in Phase III Trial

February 28, 2014

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977